RLYB Rallybio Corp: Nilai Buku Perusahaan

Logo perusahaan publik Rallybio Corp. (RLYB)

Rallybio Corporation (RLYB) specializes in developing treatments for rare blood pathologies, leveraging a robust capital reserve and the advancement of its FNAIT program. This daily price chart reflects the market reaction to therapeutic successes in treating severe congenital fetal defects and merger potential, with the metric standing at 0.09. The company's operations in the US and Europe are protected by humanitarian law and remain insulated from geopolitical risks.

RLYB Kapitalisasi Buku Rallybio (04.07.2022 - 28.10.2026)

Rincian metrik lan analitis perusahaan Rallybio Corp. (RLYB)

- rega lan prakiraan konsensus rega:
Rega bursa Rallybio Corporation|RLYB - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Rallybio Corp|RLYB - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham Rallybio|RLYB - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku rallybio.com|RLYB - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Rallybio Corporation|RLYB - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Rallybio Corporation|RLYB - Utang perusahaan|Utang marang nilai buku Rallybio Corp|RLYB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rallybio
Pambiji fundamental:RLYB - Rallybio
Barang unggulan rallybio.com

Book value capitalization represents the aggregate volume of net assets minus debt obligations, reflecting the real intrinsic value of the business. By analyzing the book value of capital chart, an investor can assess the resilience of Rallybio Corporation (RLYB) to costly clinical trials in the absence of revenue, where stagnation of this fundamental metric signals a risk of investment impairment against the high cost of therapy development.

Analisis pesaing Rallybio Corporation

HLN - Ekuitas Perusahaan|Kenvue Inc. (KVUE) - Kapitalisasi Buku|VRNA (veronapharma.com) - Nilai Buku Perusahaan|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan AQST (Aquestive Therapeutics Inc)|SCPH: Nilai Buku Perusahaan|TECX - Ekuitas Perusahaan|Aset Bersih Perusahaan Tonix Pharmaceuticals TNXP|SXTC - Total Aset Bersih|Kapitalisasi Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku EXOZ (Invizyne Technologies, Inc.)|Ekuitas Perusahaan ORMP|Entera Bio Ltd. (ENTX) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan HYFT (ipatherapeutics.com)|Nilai Buku Perusahaan ABVC BioPharma, Inc.|Nilai Akuntansi Perusahaan Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Kapitalisasi Buku|FGEN: Kapitalisasi Buku|Telomir Pharmaceuticals (TELO) - Nilai Buku Perusahaan|RANI (Rani Therapeutics Holdings, Inc.) - Nilai Buku Perusahaan|Nilai Buku Perusahaan Synergy CHC Corp.|Nilai Buku Perusahaan Lexaria (LEXX)|Pulmatrix Corp - Aset Bersih Perusahaan|Ekuitas Perusahaan ftzy.com.cn (PTHL)|Kapitalisasi Buku Aptorum Group APM|Nilai Buku Perusahaan lyratherapeutics.com LYRA|Kapitalisasi Buku IBO (Impact BioMedical Inc)|TNFA: Pambiji Buku Bisnis|Nilai Buku Perusahaan YCBD|Ekuitas Perusahaan PainReform Corp|CYTO - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan lipella.com|Kapitalisasi Buku OPTN (OptiNose)|Aset Bersih Perusahaan PIRS (Pieris Pharmaceuticals Inc)|PROC: Nilai Buku Perusahaan|Petros Pharma - Ekuitas Perusahaan|Nilai Buku Perusahaan Qilian International (QLI)|SLRN: Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan TFF Pharmaceuticals, Inc. (TFFP)